GILEAD SCIENCES, INC. Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31)
GILEAD SCIENCES, INC. (GILD) had Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) of $6.74 billion as of 2014-06-30, per its 10-Q filed 2014-08-04.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost · last filed 2014-08-04
- 2014-06-30: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $6.74B.
- 2014-03-31: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $5.51B.
- 2013-12-31: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $1.95B.
- 2013-09-30: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $2.31B.
| Period end | Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) | Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) as first filed |
|---|---|---|
| 2014-06-30 | $6.74B 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $5.51B 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $1.95B 10-K · filed 2014-02-25 | |
| 2013-09-30 | $2.31B 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $2.64B 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $2.40B 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $2.19B 10-K · filed 2013-02-27 | |
| 2012-09-30 | $2.21B 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $1.91B 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $569.75M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $9.11B 10-K · filed 2013-02-27 | |
| 2011-09-30 | $4.97B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $4.89B 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $6.32B 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $4.92B 10-K · filed 2012-02-23 | $4.40B 10-K · filed 2011-02-28 |
| 2010-09-30 | $4.22B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $2.75B 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $2.66B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |